{"name":"Phibro Animal Health","slug":"phibro","ticker":"PAHC","exchange":"NASDAQ","domain":"pahc.com","description":"Phibro Animal Health Corporation is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock.\nThe company operates through three segments Mineral Nutrition, Performance Materials, and Animal Health, from which most of its revenue is derived. The company operates in the United States, Latin America, Canada, Europe, Middle East, Africa, and Asia-Pacific. It is incorporated in Delaware.","hq":"Teaneck, NJ","founded":0,"employees":"2475","ceo":"Jack C. Bendheim","sector":"Animal Health","stockPrice":36.48,"stockChange":1.22,"stockChangePercent":3.46,"marketCap":"$1.5B","metrics":{"revenue":1500043008,"revenueGrowth":10.3,"grossMargin":32.6,"rdSpend":23726000,"netIncome":48264000,"cash":78138000,"dividendYield":1.36,"peRatio":15.7,"fiscalYear":"FY2021"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Tylan patent cliff ($10.8M at risk)","drug":"Tylan","type":"patent_expiry","sentiment":"negative"},{"date":"2025-06-01","label":"Tylan patent cliff ($10.8M at risk)","drug":"Tylan","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Phibro Animal Health Corporation Reports Fourth Quarter and Full Year 2023 Results","summary":"Phibro Animal Health Corporation (PAHC) today reported its financial results for the fourth quarter and full year 2023.","drugName":"","sentiment":"neutral"},{"date":"2023-11-14","type":"deal","headline":"Phibro Animal Health Corporation Announces the Acquisition of a Leading Animal Health Company","summary":"Phibro Animal Health Corporation (PAHC) today announced that it has acquired a leading animal health company, expanding its portfolio of innovative solutions for the livestock and poultry industries.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-05","type":"earnings","source":"simplywall.st","summary":"A Look At Phibro Animal Health (PAHC) Valuation After Strong Earnings And Zoetis MFA Integration - simplywall.st","headline":"A Look At Phibro Animal Health (PAHC) Valuation After Strong Earnings And Zoetis MFA Integration","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPTThXMXVRUDVJN1g1cWE0S1FFcGQtVWJUR0lKbkE3UmMwNkRRaXhJWjZaZ0EtZF96Smp2TU1EZUhhMWNjOHRUa1I2eFZVU1F1Z2R2V0UwNzRGWnp1OGxVVmR4YXU2NVBYYTktalhjT1dSekdRTk90cTRNVnNWeEdIamtMT05VTUlFaTFiYzcweThXdVJxZ3hRRkxCZmYwc01ZZkF2dFRzWXhLZEF6cHFELXVUeGIxeGVRcUtCeg?oc=5","date":"2026-04-01","type":"pipeline","source":"TradingView","summary":"WST Expands Dublin Facility to Boost Injectable Therapy Capacity - TradingView","headline":"WST Expands Dublin Facility to Boost Injectable Therapy Capacity","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-28","type":"pipeline","source":"simplywall.st","summary":"A Look At Phibro Animal Health (PAHC) Valuation After Recent Share Price Volatility - simplywall.st","headline":"A Look At Phibro Animal Health (PAHC) Valuation After Recent Share Price Volatility","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-26","type":"pipeline","source":"simplywall.st","summary":"Is Phibro Animal Health’s (PAHC) Efficiency Surge Quietly Rewriting Its Competitive Position in Animal Health? - simplywall.st","headline":"Is Phibro Animal Health’s (PAHC) Efficiency Surge Quietly Rewriting Its Competitive Position in Animal Health?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOUS1BOVdVbmFLdlphaU1UYWZQSGZmVmc3dTlaX2ZEQ1RYdDdkU05OWmNtUlBuNTE0NkxodW1TbUJaSzdTaGhuMXVqb2Jlci0yUTlDLXlsVl9zS19fclFLYU1IcnpNRXpfY0dHR1VSU1V2NWxkcGZySGVxVlBfMmZOQjJlVFlTMURZZHRpQWhuRFBIakhOemR0c3YybDZuTWZo?oc=5","date":"2026-03-16","type":"pipeline","source":"Yahoo Finance","summary":"BrightSpring Health Services, Collegium Pharmaceutical, and Phibro Animal Health Shares Are Soaring, What You Need To Know - Yahoo Finance","headline":"BrightSpring Health Services, Collegium Pharmaceutical, and Phibro Animal Health Shares Are Soaring, What You Need To Kn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQamgyR3h0MW9QdElEYTFBWEljdDhnWlRyUjVBV2xCR1VSYzhkWFdyMmJnUmk2TnBxUWFyWjJzYUE1R0luZHlKUGFabUVkVEoyVnRJV2tWTDFtRGd2OTNhdHhOYTVPTGpkMXEwR0pXOWRva0hpT1NjQkFQcXZDck50aUo1THlwLUpsYW9BXzZEbmNvbmduNXhJWkItbThZa0RQRzY3UWN5SGrSAbABQVVfeXFMT3NabzQxVmRFTjJ5cXZ4amwzaXpfcTN5X0JFUHl4MGhKV05QNVA0aW1jNk93andOYUVKSUFnY3BhNFU4VVdWREd6a0ZUWWh3V1V4TktmRnBoNHZ2VEhmWkV3RWpqMW1GZ3lnM3oyVU9SUG5LZzFaUlpvb1phSElpWi1TSWN0S0dpV2dJN1RWVWJjV3BRRWkwYWdzS21valJ6WUxrVlYtRGRqRzNyTDFkazA?oc=5","date":"2026-02-16","type":"deal","source":"Insider Monkey","summary":"7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds - Insider Monkey","headline":"7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-06","type":"pipeline","source":"simplywall.st","summary":"Phibro Animal Health (PAHC) Margin Rebound And EPS Surge Test Cautious Growth Narratives - simplywall.st","headline":"Phibro Animal Health (PAHC) Margin Rebound And EPS Surge Test Cautious Growth Narratives","sentiment":"neutral"},{"date":"2026-02-04","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-04","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2026-02-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOcWhtTy00TjBkVkJrTGRTSm4teF9rZDJ5MHhOd0dYSW55eTdrUHlSNFkyQ2ZsRHZ4VzFISVppUEszVFItSlUtNDJRWlN2NFRHZGE2c1VsUVJ6UUZ3WF9VbHpna1N6YVlEdFNVc2IzYURoeVRHaXVPald5bXBuUHZicHNzRmdzYndxTDlUM05aXzNSWjVzTUhLOA?oc=5","date":"2026-01-14","type":"pipeline","source":"Finviz","summary":"Reasons to Add West Pharmaceutical Stock to Your Portfolio Now - Finviz","headline":"Reasons to Add West Pharmaceutical Stock to Your Portfolio Now","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE9yQlUySW5FQjNkRkFSMGZmT1QwbDEwcGU1VWZZMDluM2QzdGFnWnlnc3VnMkFEVGNRTmI5bjFubk4ySnpzd2ZjVzdCejVzbjNaeklsYUFKVQ?oc=5","date":"2026-01-03","type":"pipeline","source":"StockStory","summary":"Phibro Animal Health (PAHC) Research Report - StockStory","headline":"Phibro Animal Health (PAHC) Research Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOWmJmb0RfbEs5UU5qajBObktsNEpPLTVkQk9LZGpzS0ZfUF9sdF9iZDhwUHd3X1ZuVEVicHJLOXNxTy1CTktod1ljejdGdl9ycTJnMV9KTkl6d21NZWhKT1hBOFZPZmhSVFBMZVNMRHNyNklSbnRmZUgzT0tGN0EzdjYzdHg?oc=5","date":"2025-10-20","type":"deal","source":"Investor's Business Daily","summary":"This Animal Health Name Keeps Chickens Clucking. The Stock Is Near A Buy Point. - Investor's Business Daily","headline":"This Animal Health Name Keeps Chickens Clucking. The Stock Is Near A Buy Point. - Investor's Business Daily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxORGxIamd0cDFlTGdzcjc3LUw1cWxVR2RvQlpWVUhfZkJGTy1GUDJtMXYwMW5FU182YnlKSl9FemFQLW0zX01Ua1lmcDNmM1RpSUg5dE1MNWRwcnBMWjZldEpNZGZtOGY1Nnkyb2RwbEpWUHIyck05ODJsbFR2MDVqZ00xZ3JuakpVd3dOR0tTRmdsdw?oc=5","date":"2025-10-09","type":"pipeline","source":"Yahoo Finance","summary":"Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health Asset for Dogs - Yahoo Finance","headline":"Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Peri","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VMXAwa1FzeThxTnRPSkxsbnhBOTg0VXJjOG5COEljVVdiR2t6VmpuNC1lN3dKNkl2amROSVA1cUN0a215WlAyNWQ4aVJqclRkSDAw?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"PAHC Stock Price, News & Analysis - Stock Titan","headline":"PAHC Stock Price, News & Analysis","sentiment":"neutral"}],"patents":[{"drugName":"Tylan","drugSlug":"tylosin","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":10800000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Zoetis Inc.","Elanco Animal Health Incorporated","Boehringer Ingelheim Animal Health"],"therapeuticFocus":["Antibiotics","Vaccines","Nutritional Supplements"],"financials":{"source":"sec_edgar+yahoo","revenue":833350000,"revenuePeriod":"2021-06-30","revenueHistory":[{"value":833350000,"period":"2021-06-30"},{"value":800354000,"period":"2020-06-30"},{"value":800354000,"period":"2020-06-30"},{"value":827995000,"period":"2019-06-30"},{"value":827995000,"period":"2019-06-30"}],"grossProfit":399942000,"grossProfitHistory":[{"period":"2025-06-30","value":399942000},{"period":"2024-06-30","value":313092000},{"period":"2023-06-30","value":298237000},{"period":"2022-06-30","value":285400000}],"rdSpend":23726000,"rdSpendHistory":[],"sgaSpend":289477000,"operatingIncome":110465000,"operatingIncomeHistory":[{"period":"2025-06-30","value":110465000},{"period":"2024-06-30","value":53315000},{"period":"2023-06-30","value":71847000},{"period":"2022-06-30","value":78986000}],"netIncome":48264000,"netIncomeHistory":[{"period":"2025-06-30","value":48264000},{"period":"2024-06-30","value":2416000},{"period":"2023-06-30","value":32606000},{"period":"2022-06-30","value":49175000}],"eps":1.19,"epsHistory":[{"period":"2025-06-30","value":1.19},{"period":"2024-06-30","value":0.06},{"period":"2023-06-30","value":0.81},{"period":"2022-06-30","value":1.21}],"cash":68039000,"cashHistory":[{"period":"2025-06-30","value":68039000},{"period":"2024-06-30","value":70613000},{"period":"2023-06-30","value":41281000},{"period":"2022-06-30","value":74248000}],"totalAssets":1360900000,"totalLiabilities":1075218000,"totalDebt":761552000,"equity":285682000,"operatingCashflow":80124000,"operatingCashflowHistory":[{"period":"2025-06-30","value":80124000},{"period":"2024-06-30","value":87594000},{"period":"2023-06-30","value":13310000},{"period":"2022-06-30","value":31649000}],"capex":-38293000,"capexHistory":[{"period":"2025-06-30","value":-38293000},{"period":"2024-06-30","value":-41238000},{"period":"2023-06-30","value":-51794000},{"period":"2022-06-30","value":-37044000}],"freeCashflow":41831000,"dividendsPaid":-19449000,"buybacks":null,"employees":2475,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":82330000,"ebit":48269000,"ebitda":61160000,"period":"2025-12-31","revenue":373910000,"epsBasic":0.68,"netIncome":27459000,"rdExpense":null,"epsDiluted":0.67,"grossProfit":132656000,"operatingIncome":50326000},{"sga":68523000,"ebit":48238000,"ebitda":61068000,"period":"2025-09-30","revenue":363893000,"epsBasic":0.65,"netIncome":26527000,"rdExpense":null,"epsDiluted":0.65,"grossProfit":119783000,"operatingIncome":51260000},{"sga":76291000,"ebit":32303000,"ebitda":44714000,"period":"2025-06-30","revenue":378697000,"epsBasic":0.42,"netIncome":17224000,"rdExpense":null,"epsDiluted":0.42,"grossProfit":110009000,"operatingIncome":33718000},{"sga":71053000,"ebit":38769000,"ebitda":51385000,"period":"2025-03-31","revenue":347825000,"epsBasic":0.52,"netIncome":20880000,"rdExpense":null,"epsDiluted":0.51,"grossProfit":104568000,"operatingIncome":33515000},{"sga":76337000,"ebit":14002000,"ebitda":25576000,"period":"2024-12-31","revenue":309261000,"epsBasic":0.08,"netIncome":3185000,"rdExpense":null,"epsDiluted":0.08,"grossProfit":101870000,"operatingIncome":25533000}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":36.48,"previousClose":35.26,"fiftyTwoWeekHigh":60.08,"fiftyTwoWeekLow":22.51,"fiftyTwoWeekRange":"22.51 - 60.08","fiftyDayAverage":52.56,"twoHundredDayAverage":43.2,"beta":0.61,"enterpriseValue":2140852864,"forwardPE":10.7,"priceToBook":4.09,"priceToSales":0.99,"enterpriseToRevenue":1.43,"enterpriseToEbitda":9.12,"pegRatio":0,"ebitda":234754000,"ebitdaMargin":15.7,"freeCashflow":-17678250,"operatingCashflow":66132000,"totalDebt":788678976,"debtToEquity":218,"currentRatio":3.17,"returnOnAssets":8.4,"returnOnEquity":30.3,"analystRating":"3.0 - Hold","recommendationKey":"hold","numberOfAnalysts":5,"targetMeanPrice":51.2,"targetHighPrice":62,"targetLowPrice":38,"dividendRate":0.48,"payoutRatio":0.21,"fiveYearAvgDividendYield":2.56,"exDividendDate":1780444800,"insiderHeldPercent":1,"institutionHeldPercent":96.2,"sharesOutstanding":21068682,"floatShares":20846208,"sharesShort":1215037,"shortRatio":4.61,"shortPercentOfFloat":3,"epsTrailing":2.33,"epsForward":3.4,"revenuePerShare":37,"bookValue":8.92,"officers":[{"age":78,"name":"Mr. Jack Clifford Bendheim","title":"Chairman, President & CEO"},{"age":53,"name":"Mr. Glenn C. David","title":"Chief Financial Officer"},{"age":61,"name":"Mr. Larry L. Miller","title":"Chief Operating Officer"},{"age":56,"name":"Ms. Judith A. Weinstein","title":"Senior VP, General Counsel & Corporate Secretary"},{"age":53,"name":"Mr. Daniel M. Bendheim J.D.","title":"Executive VP of Corporate Strategy & Director"},{"age":49,"name":"Mr. Jonathan  Bendheim","title":"Executive Vice President of Global Technology & People and Director"},{"age":63,"name":"Ms. Lisa A. Escudero","title":"Senior Vice President of Human Resources"},{"age":null,"name":"Mr. Ramon  Fuenmayor","title":"President South America Region"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://www.pahc.com","phone":"201 329 7300"}}